Isa

impak Analytics innovates with the launch of SFDR+i, a SFDR compliance solution with additional impact data covering private and listed issuers

Retrieved on: 
Thursday, March 2, 2023
Sustainable Development Goals, Isa, Software as a service, API, Brace 4 Impak, Article, Intelligence, SFDR, Data, Data collection, Article 8 of the European Convention on Human Rights, Level 2, Pais, SDG, Online shopping, Risk management

MONTREAL, PARIS, and LONDON, March 2, 2023 /PRNewswire/ -- Today, the sustainable change enabler impak Analytics is launching SFDR + i – a turnkey solution that combines SFDR and impact data from publicly-listed and private companies for the use of financial market participants. The solution gives them the means to comply with SFDR's strictest regulations and by providing users with actionable impact data, enables them to make the right decisions towards a sustainable change.

Key Points: 
  • MONTREAL, PARIS, and LONDON, March 2, 2023 /PRNewswire/ -- Today, the sustainable change enabler impak Analytics is launching SFDR + i – a turnkey solution that combines SFDR and impact data from publicly-listed and private companies for the use of financial market participants.
  • The solution gives them the means to comply with SFDR's strictest regulations and by providing users with actionable impact data, enables them to make the right decisions towards a sustainable change.
  • impak's SFDR + i offering includes the 14 mandatory Principal Adverse Impact (PAIs) (100%) and 26 of the 33 optional PAIs (78%), with the remainder soon to be integrated.
  • It is a real tour de force for our tech teams", concludes Cédric de St-Léger, CTO at impak Analytics.

impak Analytics innovates with the launch of SFDR+i, a SFDR compliance solution with additional impact data covering private and listed issuers

Retrieved on: 
Thursday, March 2, 2023
Sustainable Development Goals, Isa, Software as a service, API, Brace 4 Impak, Article, Intelligence, SFDR, Data, Data collection, Article 8 of the European Convention on Human Rights, Level 2, Pais, SDG, Online shopping, Risk management

MONTREAL, PARIS, and LONDON, March 2, 2023 /PRNewswire/ -- Today, the sustainable change enabler impak Analytics is launching SFDR + i – a turnkey solution that combines SFDR and impact data from publicly-listed and private companies for the use of financial market participants. The solution gives them the means to comply with SFDR's strictest regulations and by providing users with actionable impact data, enables them to make the right decisions towards a sustainable change.

Key Points: 
  • MONTREAL, PARIS, and LONDON, March 2, 2023 /PRNewswire/ -- Today, the sustainable change enabler impak Analytics is launching SFDR + i – a turnkey solution that combines SFDR and impact data from publicly-listed and private companies for the use of financial market participants.
  • The solution gives them the means to comply with SFDR's strictest regulations and by providing users with actionable impact data, enables them to make the right decisions towards a sustainable change.
  • impak's SFDR + i offering includes the 14 mandatory Principal Adverse Impact (PAIs) (100%) and 26 of the 33 optional PAIs (78%), with the remainder soon to be integrated.
  • It is a real tour de force for our tech teams", concludes Cédric de St-Léger, CTO at impak Analytics.

Insured American's Lifetime Healthcare Expenses May Top $700K, According to New Synchrony Research

Retrieved on: 
Monday, November 14, 2022
Adult, Generation Z, Isa, Health, Telecommunication, Digital, PETS, Gen, Awareness, Silent Generation, General of the branch, Degenerative disease, Alternative medicine, Wellness, Cancer, Insurance, NYSE, Patient, Boomer, Diabetes, Associate, One-and-a-half-stripe hap, Synchrony Financial, Solution, Health insurance, Hospital, Generation X, Synchrony, Millennials

STAMFORD, Conn., Nov. 14, 2022 /PRNewswire/ -- An insured American with an employer-sponsored health insurance plan can expect to spend more than $320,000 (including insurance premiums and out-of-pocket costs) during his/her adult lifetime, according to new consumer research from Synchrony (NYSE: SYF), a premier consumer financial services company. This number may be more than double — topping $700,000 — for Americans who purchase their own insurance (without employer or government subsidies) or for those who suffer from chronic illnesses such as diabetes, heart disease or cancer.

Key Points: 
  • As a leader in patient financing, we believe it is important to build awareness among consumers of the cost of healthcare over a lifetime."
  • Additionally, the Synchrony Lifetime of Healthcare Costs study suggests many people significantly underestimate their annual healthcare expenditures and do not save for future healthcare costs, leading many to delay recommended medical procedures, often to the detriment of their health.
  • Extrapolated during an adult lifetime, this could mean an estimated $320,000 in individual healthcare costs between the ages of 18 and 79.
  • The Lifetime of Healthcare Costs study was performed by ASQ360 Market Research/Stephens & Associates on behalf of Synchrony.

Radiance Holdings Reports Record-Breaking Growth Across its Beauty Sector Brands

Retrieved on: 
Tuesday, November 1, 2022
Sola, Growth, CEO, Freedom, Acquisition, Woodhouse, Isa, Risk, Collection, Beauty, Multimedia, Massage, Beauty salon, Tourism, Radiance

DENVER, Nov. 1, 2022 /PRNewswire/ -- Radiance Holdings, a global company representing a collection of premier brands in the beauty, wellness, and self-care sectors, announced today the highest growth since the inception of its two rapidly growing brands: Woodhouse Spa, the high-end luxury day spa franchise and Sola Salons, the world's largest and fastest-growing salon studios franchise. Closing out the year with robust expansion and development plans, Radiance Holdings is primed to continue this trajectory into Q1 and Q2 of 2023. 

Key Points: 
  • Radiance Holdings expanded Sola Salons internationally to Canada in 2022, with 9 new signings in the last 12 months.
  • Radiance Holding's mission to empower franchise owners and beauty professionals with unrivaled opportunities, mentorship, and education continues to propel these brands to new heights.
  • For more information about Radiance Holdings and its portfolio of beauty brands, please visit www.weareradianceholdings.com .
  • Radiance Holdings represents a collection of premier brands in the beauty, wellness, and self-care sectors.

MolecuLight Secures Financing from BDC Canada and iGan Partners to Support its Commercial Expansion

Retrieved on: 
Thursday, August 11, 2022
Cloud, APC, Multimedia, Isa, Industry, Food safety, CEO, Technology, Growth, Investment, ASC, Board, Patent, LLC, Elective surgery, BDC, View, Igan, Tungsten, SWK, Board of directors, DX, Intellectual, Renewable energy, Financial services, Financial adviser

The funds are to support MolecuLight's continued global expansion to meet growing customer demand for its MolecuLight i:X and DXdevices.

Key Points: 
  • The funds are to support MolecuLight's continued global expansion to meet growing customer demand for its MolecuLight i:X and DXdevices.
  • "We have invested in MolecuLight since inception and are thrilled to see the company achieve global commercial success," says Sam Ifergan, Founder and President of iGan Partners.
  • "BDC is proud to participate in the financing of MolecuLight, an impressive Canadian company that is making a global impact in terms of improving healthcare outcomes," says Leonard Kofman, Partner with BDC Capital's Intellectual Property-Backed Financing practice.
  • iGan provides portfolio companies with smart-capital, active support, and access to a network of industry partners and sector-specific co-investors to help them grow and succeed.

MolecuLight Secures Financing from BDC Canada and iGan Partners to Support its Commercial Expansion

Retrieved on: 
Thursday, August 11, 2022
Cloud, APC, Isa, Industry, Food safety, CEO, Technology, Growth, Investment, ASC, Board, Patent, LLC, Elective surgery, BDC, Igan, Tungsten, SWK, Board of directors, DX, Intellectual, Renewable energy, Financial services, Financial adviser

TORONTO, Aug. 11, 2022 /PRNewswire/ -- MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announced that it has completed a financing with BDC Capital and iGan Ventures. The funds are to support MolecuLight's continued global expansion to meet growing customer demand for its MolecuLight i:X® and DX™ devices. Leonard Kofman and Jody Staggs, Managing Director of SWK Holdings will join MolecuLight's Board of Directors as observers.

Key Points: 
  • The funds are to support MolecuLight's continued global expansion to meet growing customer demand for its MolecuLight i:X and DXdevices.
  • "We have invested in MolecuLight since inception and are thrilled to see the company achieve global commercial success," says Sam Ifergan, Founder and President of iGan Partners.
  • "BDC is proud to participate in the financing of MolecuLight, an impressive Canadian company that is making a global impact in terms of improving healthcare outcomes," says Leonard Kofman, Partner with BDC Capital's Intellectual Property-Backed Financing practice.
  • iGan provides portfolio companies with smart-capital, active support, and access to a network of industry partners and sector-specific co-investors to help them grow and succeed.

Carrum Health Selects Novant Health as Its First Centers of Excellence Partner in North Carolina

Retrieved on: 
Tuesday, August 9, 2022
Multicultural and diversity management, Novant Health, Multimedia, Hospital, Quality, Isa, Patient safety, Patient, CEO, Metabolism, Bariatric surgery, Center, Silicon, Society, Excellent, American College, RAND Corporation, View, Partnership, Fellowship of the Royal Colleges of Surgeons, Accreditation, Carrum, Victoria, COE, Physician, Digital, Tiger Global Management, Woman, Adoption, Medicine, Health insurance

SAN FRANCISCO, Aug. 9, 2022 /PRNewswire/ -- Carrum Health, the first digital health company connecting employers and employees to Centers of Excellence (COEs) through a technology-powered value-based care platform, today announced it is partnering with Novant Health to deliver orthopedic and bariatric care to Carrum Health members in North Carolina. 

Key Points: 
  • High-Quality Orthopedic and Bariatric Care Now Available to Carrum Members at Novant Health Facilities in Charlotte, N.C.
    SAN FRANCISCO, Aug. 9, 2022 /PRNewswire/ -- Carrum Health , the first digital health company connecting employers and employees to Centers of Excellence (COEs) through a technology-powered value-based care platform, today announced it is partnering with Novant Health to deliver orthopedic and bariatric care to Carrum Health members in North Carolina.
  • As an innovative leader in providing patient-centered care, Novant Health is the first Carrum Health COE partner in North Carolina, offering significant value, personalized care navigation and the latest in high-quality treatment options for both patients and their employers.
  • Initially, this partnership will provide convenient access to care at Novant Health Charlotte Orthopedic Hospital and Novant Health Presbyterian Medical Center, with potential to add additional services and evaluate expansion into other regions of the Novant Health footprint.
  • "The clinical strength of Novant Health's programs isexceptional and will give our employers in the region access to top-quality care," said Sach Jain, CEO and founder of Carrum Health.

Field Trial Success Drives Advancement in Asian Soybean Rust Resistance

Retrieved on: 
Wednesday, July 20, 2022
Group, Disease resistance, Isa, Biotechnology, Corteva, Soybean, Crop protection, Sainsbury Laboratory, Farmer, NYSE, Faculdade de Medicina da Universidade Federal de Minas Gerais, Agriculture, Partnership, Genetics, Solution, Risk, Multimedia, Organization, Gene, AG, Canker, ASR, Disease, Growth

EVANSTON, Ill., and INDIANAPOLIS, July 20, 2022 /PRNewswire/ -- Today, 2Blades and Corteva Agriscience announced they have reached a milestone in their collaboration to develop a transgene for Asian Soybean Rust (ASR) resistance with successful field trials of Latin American soybean varieties containing the new ASR transgene. This achievement marks an important point in the research collaboration between the two organizations, which seeks to develop durable resistance and minimize grower losses due to the plant pathogen.

Key Points: 
  • EVANSTON, Ill., and INDIANAPOLIS, July 20, 2022 /PRNewswire/ -- Today, 2Blades and Corteva Agriscience announced they have reached a milestone in their collaboration to develop a transgene for Asian Soybean Rust (ASR) resistance with successful field trials of Latin American soybean varieties containing the new ASR transgene.
  • "Results from the trial showed strong disease resistance in the transgenic soybean varieties tested," said Dr. Tom Greene, Biotechnology Leader at Corteva Agriscience.
  • 2Blades' knowledge of disease resistance, combined with Corteva's laboratory and field testing proficiency, as well as product development expertise, prompted the initial decision to collaborate in 2013.
  • While scientific advancements have led to some improvements in soybean rust control in countries such as Brazil, durable genetic resistance is an important tool for farmers to mitigate the risk of the disease.

MolecuLightDX™ Wins Award as a Top Innovation in Wound Care 2022 From Wound Management & Prevention Journal

Retrieved on: 
Thursday, July 7, 2022
Health, View, Patient, Madigan Army Medical Center, Food safety, ASC, Isa, Decision-making, Elective surgery, History, Technology, WA, Standard of care, Skin, WMP, DX, Board, APC, News, Multimedia, Education, Medicine, Medical imaging

Based on its extensive body of evidence and interviews with clinicians using it, the MolecuLight device is changing the standard of care in wound care.

Key Points: 
  • Based on its extensive body of evidence and interviews with clinicians using it, the MolecuLight device is changing the standard of care in wound care.
  • "Wound Management & Preventionis dedicated to featuring the top innovations in wound care," said Christiane Odyniec, Managing Editor.
  • "Each July, theWMPEditorial Board nominates the newest innovations in the field of wound care, with the goal of sharing information to improve patient care.
  • "Using MolecuLight has revolutionized our wound care practice and now allows us to provide proactive wound care," says Dr. Andersen.

MolecuLightDX™ Wins Award as a Top Innovation in Wound Care 2022 From Wound Management & Prevention Journal

Retrieved on: 
Thursday, July 7, 2022
Health, Patient, Madigan Army Medical Center, Food safety, ASC, Isa, Decision-making, Elective surgery, History, Technology, WA, Standard of care, Skin, WMP, DX, Board, APC, News, Education, Medicine, Medical imaging

Based on its extensive body of evidence and interviews with clinicians using it, the MolecuLight device is changing the standard of care in wound care.

Key Points: 
  • Based on its extensive body of evidence and interviews with clinicians using it, the MolecuLight device is changing the standard of care in wound care.
  • "Wound Management & Preventionis dedicated to featuring the top innovations in wound care," said Christiane Odyniec, Managing Editor.
  • "Each July, theWMPEditorial Board nominates the newest innovations in the field of wound care, with the goal of sharing information to improve patient care.
  • "Using MolecuLight has revolutionized our wound care practice and now allows us to provide proactive wound care," says Dr. Andersen.